Ambani Orgochem

Q2 FY27

Ambani Orgochem Q2 FY27 results statement: Revenue & Margins

Q2 FY27 results statement: what the company reported on revenue, margins and projects.

Price₹162

Market cap₹140 Cr

P/E102.7

Updated15 Oct 2026

Read3 min read

Based on Ambani Orgochem's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

The short version

Revenue from operations (net of taxes) for the half year ended September 30, 2026: ₹16,998.03 lakhs, compared to ₹10,915.18 lakhs for the same period in 2025, indicating a year-on-year increase of approximately 55.7%. The results statement reports the following for the quarter ended September 30, 2026: - EBITDA: ₹1,916 million, a 46% YoY increase.

From Ambani Orgochem's Q2 FY27 earnings-call transcript · updated 15 Oct 2026.

Revenue & Sales Performance

Revenue from operations (net of taxes) for the half year ended September 30, 2026: ₹16,998.03 lakhs, compared to ₹10,915.18 lakhs for the same period in 2025, indicating a year-on-year increase of approximately 55.7%.
Total income from operations (net) for the half year ended September 30, 2026: ₹17,122.12 lakhs versus ₹11,055.94 lakhs in H1 2025, a rise of around 54.9%.
The presentation does not provide explicit sales volume figures.
No explicit outlook or guidance for future revenue or volume growth is stated in the presentation.

Profitability & Margins

See what Ambani Orgochem said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The provided document does not contain any investor presentation or details specifically describing capex, capacity expansion, new plant, or project amounts, statuses, or timelines. It primarily contains the company's financial results, cash flow statements, notes, and disclosures for the half year ended September 30, 2026. There is no mention of capital expenditure plans, capacity expansion, or new project developments in the provided pages.

Fundraising & Capital Structure

The company raised equity by receiving the balance 75% of the issue price from allottees towards conversion of 12,60,000 outstanding warrants into equity shares during the half year ended September 30, 2026.
Proceeds from the issue of shares amounted to ₹850.50 Lakhs in the half year ended 30.09.2026.
There was an increase in long-term borrowings by ₹695.80 Lakhs from 31.03.2026 to 30.09.2026.
Short-term borrowings decreased slightly by ₹54.25 Lakhs in the same period.
Net borrowings (long-term plus short-term) increased during the half year ended 30.09.2026.
The company redeemed 45,52,320 Preference Shares amounting to ₹4,55,23,200 in accordance with the Companies Act during the period.

2 more points from Ambani Orgochem's call on fundraising

Pro opens every point from 15K+ earnings calls

See what Ambani Orgochem said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The presentation does not mention or report any details on order book, order inflow, or pending orders. The disclosed information primarily focuses on: - Unaudited standalone and consolidated financial results for the half year ended September 30, 2026. - Key financial metrics such as revenue, profit, cash flows, and borrowings. - Notes on insurance claim related to a fire incident at Dahej factory. - Capital redemption and share allotment details.

2 more points from Ambani Orgochem's call on order book

Pro opens every point from 15K+ earnings calls

What Ambani Orgochem's management said in earlier quarters

Q1 FY27 earnings call analysis →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Ambani Orgochem and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Ambani Orgochem Q2 FY27 results?

What is Ambani Orgochem share price analysis?

Ambani Orgochem currently shows a neutral. The stock trades at a P/E of 102.7 with a market cap of ₹140 Cr. Investors should review the full earnings analysis for detailed insights.

Is Ambani Orgochem planning capital expenditure?

The provided document does not contain any results statement or details specifically describing capex, capacity expansion, new plant, or project amounts, statuses, or timelines.

Keep Ambani Orgochem on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.